Cargando…
SRSF1 induces glioma progression and has a potential diagnostic application in grading primary glioma
Glioma is the most common intracranial tumor of the central nervous system in adults; however, the diagnosis of glioma, and its grading and histological subtyping, is challenging for pathologists. The present study assessed serine and arginine rich splicing factor 1 (SRSF1) expression in 224 glioma...
Autores principales: | Ye, Li-Juan, Xu, Kai-Min, Bai, Gang, Yuan, Jing, Ran, Feng-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326825/ https://www.ncbi.nlm.nih.gov/pubmed/37427339 http://dx.doi.org/10.3892/ol.2023.13934 |
Ejemplares similares
-
Re-irradiation for high-grade gliomas: Has anything changed?
por: García-Cabezas, Sonia, et al.
Publicado: (2021) -
Diagnostic value of MRI radiomics in differentiating high‑grade glioma from low‑grade glioma: A meta‑analysis
por: Wang, Jiefang, et al.
Publicado: (2023) -
Application of intraoperative ultrasound in the resection of high-grade gliomas
por: Wei, RenJie, et al.
Publicado: (2023) -
Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas
por: Broggi, Giuseppe, et al.
Publicado: (2021) -
WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
por: Varlet, Pascale, et al.
Publicado: (2020)